Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3 USD | -1.78% | -18.92% | -27.88% |
Sales 2024 * | 7.3M 5.31M | Sales 2025 * | 9.12M 6.63M | Capitalization | 2.51M 1.82M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.34 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.27 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 13 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.64% |
Latest transcript on InMed Pharmaceuticals Inc.
1 day | -1.78% | ||
1 week | -18.92% | ||
Current month | -17.58% | ||
1 month | -16.67% | ||
3 months | -16.67% | ||
6 months | -53.42% | ||
Current year | -27.88% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-15 |
Chief Operating Officer | - | 18-11-04 | |
Colin Clancy
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Janet Grove
BRD | Director/Board Member | 57 | 22-02-10 |
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-15 |
Andrew Hull
CHM | Chairman | 61 | 16-09-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 0.3 | -1.78% | 260,209 |
24-04-16 | 0.3054 | -4.16% | 806,885 |
24-04-15 | 0.3187 | -3.28% | 103,193 |
24-04-12 | 0.3295 | -1.64% | 67,463 |
24-04-11 | 0.335 | -9.46% | 1,038,881 |
Delayed Quote Nasdaq, April 17, 2024 at 04:00 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.88% | 1.82M | |
-3.39% | 102B | |
+2.61% | 96.84B | |
-1.02% | 21.48B | |
-18.14% | 20.82B | |
-6.87% | 18.6B | |
-40.70% | 16.81B | |
-26.89% | 13.78B | |
+1.12% | 13.4B | |
+22.25% | 11.06B |
- Stock Market
- Equities
- INM Stock